- Home
- GAB vs TVTX Comparison
GAB vs TVTX Comparison
Compare GAB & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAB
- TVTX
- Stock Information
- Founded
- GAB 1986
- TVTX 2008
- Country
- GAB United States
- TVTX United States
- Employees
- GAB N/A
- TVTX N/A
- Industry
- GAB Investment Managers
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- GAB Finance
- TVTX Health Care
- Exchange
- GAB Nasdaq
- TVTX Nasdaq
- Market Cap
- GAB 1.8B
- TVTX 1.8B
- IPO Year
- GAB N/A
- TVTX N/A
- Fundamental
- Price
- GAB $5.51
- TVTX $21.01
- Analyst Decision
- GAB
- TVTX Strong Buy
- Analyst Count
- GAB 0
- TVTX 11
- Target Price
- GAB N/A
- TVTX $26.18
- AVG Volume (30 Days)
- GAB 667.8K
- TVTX 1.3M
- Earning Date
- GAB 01-01-0001
- TVTX 02-18-2025
- Dividend Yield
- GAB 10.91%
- TVTX N/A
- EPS Growth
- GAB N/A
- TVTX N/A
- EPS
- GAB N/A
- TVTX N/A
- Revenue
- GAB N/A
- TVTX $203,447,000.00
- Revenue This Year
- GAB N/A
- TVTX $62.37
- Revenue Next Year
- GAB N/A
- TVTX $61.74
- P/E Ratio
- GAB N/A
- TVTX N/A
- Revenue Growth
- GAB N/A
- TVTX 57.08
- 52 Week Low
- GAB $4.56
- TVTX $5.12
- 52 Week High
- GAB $5.88
- TVTX $21.56
- Technical
- Relative Strength Index (RSI)
- GAB 48.88
- TVTX 56.52
- Support Level
- GAB $5.43
- TVTX $19.78
- Resistance Level
- GAB $5.61
- TVTX $21.40
- Average True Range (ATR)
- GAB 0.07
- TVTX 1.17
- MACD
- GAB 0.00
- TVTX 0.12
- Stochastic Oscillator
- GAB 37.50
- TVTX 71.85
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.